Profile data is unavailable for this security.
About the company
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.
- Revenue in HKD (TTM)7.74bn
- Net income in HKD1.53bn
- Incorporated2006
- Employees5.78k
- LocationChina Medical System Holdings LtdUnit 2106, 21/F, Island Place Tower, 510, North Point Hong KongHKG
- Phone+86 75 582416868
- Fax+86 75 582416622
- Websitehttps://web.cms.net.cn/zh/home/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SSY Group Ltd | 6.47bn | 1.37bn | 11.30bn | 5.80k | 8.30 | 1.56 | 6.18 | 1.75 | 0.4593 | 0.4593 | 2.18 | 2.44 | 0.5418 | 2.75 | 3.07 | 1,155,141.00 | 11.54 | 10.51 | 14.88 | 14.03 | 54.39 | 58.72 | 21.30 | 18.62 | 2.06 | 28.65 | 0.323 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
| Luye Pharma Group Ltd | 6.96bn | 849.73m | 11.36bn | 5.27k | 13.37 | 0.7912 | 6.64 | 1.63 | 0.2259 | 0.2259 | 1.85 | 3.82 | 0.236 | 2.44 | 2.84 | 1,321,269.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 2.96 | 0.4016 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| Shanghai Henlius Biotech Inc | 6.22bn | 763.57m | 12.53bn | 3.55k | 16.45 | 4.41 | 10.70 | 2.01 | 1.40 | 1.40 | 11.40 | 5.23 | 0.5764 | 1.90 | 6.82 | 1,710,433.00 | 7.07 | -8.59 | 14.25 | -14.14 | 73.23 | 71.77 | 12.27 | -27.37 | 0.329 | 6.86 | 0.6113 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| 3SBio Inc | 9.29bn | 1.83bn | 13.65bn | 5.61k | 7.59 | 0.8539 | 6.02 | 1.47 | 0.7509 | 0.7509 | 3.81 | 6.68 | 0.3575 | 1.52 | 6.73 | 1,716,495.00 | 7.25 | 7.44 | 10.26 | 9.29 | 85.94 | 82.91 | 20.27 | 21.50 | 1.57 | 23.87 | 0.1998 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
| Grand Pharmaceutical Group Ltd | 10.59bn | 2.41bn | 15.37bn | 10.78k | 6.29 | 0.9778 | 5.34 | 1.45 | 0.6885 | 0.6885 | 3.03 | 4.43 | 0.4472 | 3.62 | 3.21 | 1,005,064.00 | 10.25 | 10.09 | 14.21 | 14.01 | 59.00 | 61.97 | 22.92 | 22.35 | 1.09 | -- | 0.2232 | 26.94 | 10.12 | 12.06 | -9.59 | 21.41 | 5.69 | 24.77 |
| Simcere Pharmaceutical Group Ltd | 6.99bn | -1.22bn | 15.79bn | 7.03k | -- | 2.15 | -- | 2.26 | -0.4648 | -0.4648 | 2.72 | 2.91 | 0.5198 | 2.19 | 2.64 | 995,369.40 | -9.04 | 10.17 | -11.71 | 15.60 | 77.02 | 78.82 | -17.40 | 17.50 | 1.88 | 0.4709 | 0.1461 | 46.68 | 4.49 | 7.92 | -23.22 | -0.5213 | 23.93 | -- |
| The United Laboratories Intl. Hldgs Ltd. | 15.45bn | 3.21bn | 15.83bn | 15.00k | 4.93 | 1.06 | 4.13 | 1.02 | 1.77 | 1.77 | 8.50 | 8.21 | 0.6578 | 3.30 | 3.54 | 1,030,028.00 | 13.65 | 7.89 | 20.72 | 12.64 | 46.15 | 44.17 | 20.75 | 12.73 | 1.72 | -- | 0.1532 | 28.99 | 21.22 | 12.84 | 70.85 | 31.66 | 24.19 | 46.04 |
| Zai Lab Ltd | 2.52bn | -2.33bn | 16.40bn | 2.18k | -- | 2.94 | -- | 6.52 | -2.39 | -2.39 | 2.59 | 5.59 | 0.3083 | 3.04 | 5.52 | -- | -28.50 | -37.72 | -34.92 | -42.72 | 63.17 | 64.75 | -92.44 | -282.44 | 3.29 | -- | 0.0908 | -- | 24.03 | 360.03 | 24.51 | -- | -3.45 | -- |
| China Medical System Holdings Ltd | 7.74bn | 1.53bn | 19.08bn | 5.78k | 12.46 | 1.08 | 10.73 | 2.47 | 0.6276 | 0.6276 | 3.16 | 7.26 | 0.384 | 2.89 | 5.65 | 1,356,928.00 | 7.51 | 18.44 | 8.53 | 21.14 | 74.13 | 75.47 | 19.56 | 34.26 | 3.97 | -- | 0.0667 | 40.14 | -12.43 | 8.08 | -26.33 | 5.35 | 38.69 | 5.19 |
| China Traditional Chinese Med Hldg CoLtd | 18.97bn | 1.01bn | 21.91bn | 17.30k | 21.65 | 0.9294 | 9.49 | 1.15 | 0.2009 | 0.2009 | 3.77 | 4.68 | 0.453 | 1.54 | 1.76 | 1,096,593.00 | 2.62 | 4.60 | 4.01 | 7.07 | 49.86 | 57.07 | 5.77 | 9.77 | 1.51 | 6.63 | 0.1808 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
| HUTCHMED (China) Ltd | 4.76bn | -327.14m | 23.70bn | 1.97k | -- | 4.11 | -- | 4.98 | -0.3893 | -0.3893 | 5.52 | 6.62 | 0.4775 | 7.10 | 4.15 | 2,394,864.00 | -3.30 | -14.35 | -4.65 | -20.43 | 41.67 | 36.57 | -6.91 | -31.44 | 2.68 | -- | 0.0984 | -- | 96.52 | 31.38 | 127.93 | -- | 38.65 | -- |
| WuXi XDC Cayman Inc | 3.08bn | 655.72m | 24.22bn | 1.50k | 37.47 | 3.66 | 32.21 | 7.86 | 0.539 | 0.539 | 2.73 | 5.51 | 0.5586 | 21.31 | 2.62 | 2,617,298.00 | 11.88 | -- | 15.43 | -- | 30.96 | -- | 21.27 | -- | 4.02 | 204.82 | 0.0113 | -- | 114.44 | -- | 82.07 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to China Medical System Holdings Ltd's reporting currency: Hong Kong Dollar HKD
9.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Sep 2024 | 46.74m | 1.92% |
| Lazard Asset Management LLCas of 31 Jul 2024 | 36.80m | 1.51% |
| Dimensional Fund Advisors LPas of 05 Sep 2024 | 33.25m | 1.36% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 21.63m | 0.89% |
| Fidelity Management & Research Co. LLCas of 31 Jul 2024 | 20.62m | 0.85% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 17.38m | 0.71% |
| BlackRock Fund Advisorsas of 05 Sep 2024 | 15.30m | 0.63% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 14.74m | 0.60% |
| Lazard Asset Management Ltd.as of 31 Jul 2024 | 9.70m | 0.40% |
| Principal Global Investors (Hong Kong) Ltd.as of 30 Jun 2024 | 8.24m | 0.34% |
More ▼
Data from 31 Dec 2023 - 19 Sep 2024Source: FactSet Research Systems Inc.
